clioquinol has been researched along with kanamycin a in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Baran, D; Gillet, P; Henri, J | 1 |
Ermol'eva, ZV; Kereselidze, TS | 1 |
Beargie, RA; Belin, RP; Bryant, LR; Griffin, WO; Medley, ES; Richardson, JD | 1 |
Bass, TM | 1 |
JADIN, J; WERY, M | 1 |
1 review(s) available for clioquinol and kanamycin a
Article | Year |
---|---|
[Prevention of cholera by antibiotics].
Topics: Anti-Bacterial Agents; Carrier State; Chloramphenicol; Cholera; Clioquinol; Disease Outbreaks; Drug Resistance, Microbial; Erythromycin; Humans; Kanamycin; Nitrofurans; Paromomycin; Streptomycin; Tetracycline; Vibrio | 1971 |
6 other study(ies) available for clioquinol and kanamycin a
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The treatment of enteritis in infants with the kanamycin-sulfadiazine-iodochloroxy-quinolein drug combination].
Topics: Clioquinol; Enteritis; Humans; Infant; Infant, Newborn; Kanamycin; Sulfadiazine | 1965 |
Transit time and bacterial overgrowth as determinants of absorptive capacity.
Topics: Clioquinol; Colon; Dehydration; Diarrhea; Fatty Acids, Nonesterified; Gastrointestinal Motility; Growth; Humans; Immunoglobulins; Infant, Newborn; Infant, Newborn, Diseases; Intestinal Absorption; Intestine, Small; Intestines; Kanamycin; Lipids; Male; Parenteral Nutrition; Postoperative Complications; Time Factors | 1972 |
[Occurrence of cultures with episomal resistance to antibiotics among shigellae isolated in Kiev].
Topics: Ampicillin; Chloramphenicol; Clioquinol; Erythromycin Ethylsuccinate; Escherichia coli; Furazolidone; Humans; Kanamycin; Nalidixic Acid; Neomycin; Nitro Compounds; Nitrofurans; Nitrofurazone; Oxyquinoline; Penicillin Resistance; Plasmids; Polymyxins; Recombination, Genetic; Rifampin; Shigella flexneri; Shigella sonnei; Streptomycin; Tetracycline; Ukraine | 1974 |
[The importance of drug associations in the treatment of diarrhea].
Topics: Bacillus; Clioquinol; Diarrhea; Dysentery; Dysentery, Amebic; Dysentery, Bacillary; Entamoeba histolytica; Escherichia coli; Humans; Kanamycin; Klebsiella; Neomycin; Proteus; Salmonella; Shigella; Staphylococcus; Streptomycin; Sulfadiazine | 1962 |